| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
778 |
628 |
$10K |
| 99497 |
|
26 |
24 |
$861.39 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
31 |
28 |
$754.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
17 |
16 |
$492.79 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
32 |
26 |
$408.77 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
28 |
25 |
$246.98 |
| 99406 |
|
24 |
21 |
$122.56 |
| 3078F |
|
244 |
225 |
$0.78 |
| 1125F |
|
136 |
121 |
$0.49 |
| 3074F |
|
177 |
164 |
$0.49 |
| 1126F |
|
61 |
55 |
$0.13 |
| 1160F |
|
269 |
247 |
$0.03 |
| 1159F |
|
269 |
247 |
$0.03 |
| 1101F |
|
241 |
221 |
$0.00 |
| G9664 |
Patients who are currently statin therapy users or received an order (prescription) for statin therapy |
29 |
28 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
19 |
17 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
20 |
18 |
$0.00 |